What does Seroba Life Sciences invest in?
Seroba Life Sciences invests most often at Series A and Series B (71% of the rounds on record), in sectors such as Telehealth, Digital-health and E-health.

Ireland · Investor
Last cheque observed Jan 2025. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.
QuietNew fund $1.0M, Oct 2023VC firm
Follow Seroba Life Sciences and see its new cheques in your feed.Start following
7 rounds on record
Mostly Series A and Series B: 71% of its rounds
Every round we can evidence, newest first7 appearances
1 round
1 round
4 rounds
1 round
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
Named by the firm itself, on a filing, its Form ADV or its company registration6 named
We also hold 4 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
From their own portfolio page (on their website)
AzafarosFusion PharmaceuticalsMedlumicsPerfuzeRyme MedicalShiratronicsShorla OncologyStorm TherapeuticsLabcyteLociPalliarePrecision BioticsSibyllaVeryan
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.
The investors most often in the same rounds as Seroba Life Sciences. A count of rooms they were both in, not a relationship either has claimed.
The latest companies Seroba Life Sciences put money into.
Seroba Life Sciences invests most often at Series A and Series B (71% of the rounds on record), in sectors such as Telehealth, Digital-health and E-health.
7 investments on record, 0 of them in the last 12 months. The most recent was in Jan 2025.
Its most recent investments on record: Coave Therapeutics (Series A, Jan 2025), Sibylla Biotech (Series A, Jan 2023) and Endotronix (Series D, Oct 2019).
The median round it joins is $33M. It says it writes cheques of $100K to $7.0M.
Rarely, if at all: none of its 7 investments on record names it as the lead.
Most of the companies it backs are in the United Kingdom (29%), Canada (29%) and France (14%).
No investments in the last 12 months; the latest was in Jan 2025.
Most often Adams Street Partners (2 rounds together) and Varian (2 rounds together).
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it